Progrès vers l'élimination de l'hépatite B et de l'hépatite C à l'aide d'un modèle de financement catalytique - Tachkent, Ouzbékistan, 6 décembre 2019-15 mars 2020
Summary In 2016, the World Health Organization (WHO) set hepatitis elimination targets of 90% reduction in incidence and 65% reduction in mortality worldwide by 2030 (1). Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection prevalences are high in Uzbekistan, which lacks funding for meeting WHO’s targets. In the absence of large financial donor […]